[1] |
Garreta-Lara E,Checa A,Fuchs D, et al. Effect of psychiatric drugs on daphnia magna oxylipin profiles[J]. Sci Total Environ, 2018, 644: 1101-1109.
|
[2] |
Moolenaar WH,Perrakis A. Insights into autotaxin: how to produce and present a lipid mediator[J]. Nat Rev Mol Cell Biol, 2011, 12(10): 674-679.
|
[3] |
Cartier A,Hla T. Sphingosine 1-phosphate: lipid signaling in pathology and therapy[J]. Science, 2019, 366(6463): 5551.
|
[4] |
Michos ED,McEvoy JW,Blumenthal RS. Lipid management for the prevention of atherosclerotic cardiovascular disease[J]. N Engl J Med, 2019, 381(16): 1557-1567.
|
[5] |
Backes JM,Ruisinger JF,Gibson CA, et al. Statin-associated muscle symptoms-managing the highly intolerant[J]. J Clin Lipidol, 2017, 11(1): 24-33.
|
[6] |
Quispe R,Hendrani A,Elshazly MB, et al. Accuracy of low-density lipoprotein cholesterol estimation at very low levels[J]. BMC Med, 2017, 15(1): 83.
|
[7] |
Martin SS,Blaha MJ,Elshazly MB, et al. Comparison of a novel method vs the friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile[J]. JAMA, 2013, 310(19): 2061-2068.
|
[8] |
Sathiyakumar V,Park J,Golozar A, et al. Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy[J]. Circulation, 2018, 137(1): 10-19.
|
[9] |
US Preventive Services Task Force, Bibbins-Domingo K,Grossman DC, et al. Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement[J]. JAMA, 2016, 316(19): 1997-2007.
|
[10] |
刘海英,江涛.高压氧干预对颅脑损伤患者脑氧代谢、脑损伤及氧化应激反应的影响[J].海南医学院学报, 2018, 24(18): 1661-1665.
|
[11] |
Rodríguez-Rodríguez A,Egea-Guerrero JJ,Murillo-Cabezas F, et al. Oxidative stress in traumatic brain injury[J]. Curr Med Chem, 2014, 21(10): 1201-1211.
|
[12] |
王玖红.脑脊液生化指标对中枢神经系统性疾病患者病情严重程度的评估价值[J].检验医学与临床, 2019, 16(20): 3043-3045.
|
[13] |
Rahimi J,Woehrer A. Overview of cerebrospinal fluid cytology[J]. Handb Clin Neurol, 2017, 145: 563-571.
|
[14] |
Surmiak M,Gielicz A,Stojkov D, et al. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis[J]. J Lipid Res, 2019, Epub ahead of print.
|
[15] |
Loell I,Alemo Munters L,Pandya J, et al. Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis[J]. Ann Rheum Dis, 2013, 72(2): 293-299.
|
[16] |
Bhatt L,Roinestad K,Van T, et al. Recent advances in clinical development of leukotriene B4 pathway drugs[J]. Semin Immunol, 2017, 33(11): 65-73.
|
[17] |
Snyder NW,Golin-Bisello F,Gao Y, et al. 15-oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways[J]. Chem Biol Interact, 2015, 234(5): 144-153.
|
[18] |
Abbasi S,Kajimoto K,Harashima H. Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion[J]. Int J Nanomedicine, 2016, 11(8): 2685-2694.
|
[19] |
Luo YY,Wu SH,Lu HY, et al. Lipoxin A4 attenuates hyperoxia-induced lung epithelial cell injury via the upregulation of heme oxygenase-1 and inhibition of proinflammatory cytokines[J]. Mol Med Rep, 2019, Epub ahead of print.
|
[20] |
Ke Y,Zebda N,Oskolkova O, et al. Anti-inflammatory effects of OxPAPC involve endothelial cell-mediated generation of LXA4[J]. Circ Res, 2017, 121(3): 244-257.
|
[21] |
Luo X,Gu Y,Tao X, et al. Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of d-series resolvins in chemotherapy-induced peripheral neuropathy[J]. Front Pharmacol, 2019, 10: 745.
|